# A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Source: https://onco.cc/trials/nct07020221/  
OnCo record `nct07020221` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of VS-7375, Cetuximab, Carboplatin in pancreatic ductal adenocarcinoma and non-small-cell lung cancer, run by Verastem, Inc., now recruiting.

## Summary

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors is a phase 1/2 interventional study registered as NCT07020221 by Verastem, Inc., with 295 participants planned, started 2025-06-24 and due to reach its primary completion in 2028-12. Interventions recorded: VS-7375, Cetuximab, Carboplatin + Pemetrexed + Pembrolizumab, Gemcitabine, Gemcitabine + Nab-paclitaxel. Conditions listed: Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer, Colorectal Cancer, Solid Tumor, Adult. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT07020221
- Phase: 1/2
- Setting: A Phase 1/2, Open-label Study of VS-7375, a KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and in Combination, in Patients With Advanced KRAS G12D-Mutated Solid Tumors
- Sponsor: Verastem, Inc.
- Enrolled: 295

## Sources

- ClinicalTrials.gov NCT07020221: https://clinicaltrials.gov/study/NCT07020221

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/), [Small-cell lung cancer](https://onco.cc/cancers/sclc/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Cetuximab](https://onco.cc/drugs/cetuximab/), [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Pembrolizumab](https://onco.cc/drugs/pembrolizumab/), [Pemetrexed](https://onco.cc/drugs/pemetrexed/), [VS-7375](https://onco.cc/drugs/vs-7375/)
- companies: [Verastem Oncology](https://onco.cc/companies/verastem/)

---
JSON: https://onco.cc/api/v1/entities/nct07020221.json